Christelle Ferrà i Coll

Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study

Virginia Escamilla Gómez, Valentín García‐Gutiérrez, Lucía López‐Corral et al. · Bone Marrow Transplantation · 2019 · 90 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +7

Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir

Genovefa A. Papanicolaou, Robin K. Avery, Catherine Cordonnier et al. · Clinical Infectious Diseases · 2023 · 54 citations · Full text

Veterinary Medicine, Hematology, Infectious Diseases +10

Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial

Teresa Caballero‐Velázquez, Isabel Montero, Fermín Sánchez‐Guijo et al. · Clinical Cancer Research · 2016 · 44 citations · Full text

Medicine, Immunology, Pharmacotherapy +15

Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) Polymorphisms

Estrella Carrillo‐Cruz, José R. García‐Lozano, Francisco J. Márquez‐Malaver et al. · Clinical Cancer Research · 2019 · 12 citations

Life Sciences, Immunology, Molecular Medicine +17

Treatment of steroid‐refractory chronic graft‐versus‐host disease with imatinib: Real‐life experience of the Spanish group of hematopoietic transplantation (GETH)

Ingrid Parra Salinas, Aránzazu Bermúdez, Lucía López‐Corral et al. · Clinical Transplantation · 2021 · 10 citations

Pharmacy, Hematology, Pharmacotherapy +8